The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90).The Company to Expand the Study into Additional Trial Sites in EuropePhiladelphia, ...

Advarra has integrated its Center for IRB Intelligence (CIRBI) with the Study Collaboration for visibility into trial site ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing ...

The commission received unsolicited information regarding FAMU in March, SACSCOC Vice President Geoffrey Klein told the ...

The meeting served as a platform to review the University’s recent milestones, which continue to cement its position as a ...

The Dharamashastra National Law University (DNLU) - Journal of Legal Studies (DNLU-JLS) has invited interested persons to ...

SINGAPORE] Investors in Singapore are behind their regional peers in several climate-related metrics, particularly on matters ...

UK hedge fund Palliser Capital is ramping up its campaign for Rio Tinto to abandon its London listing, challenging the mining ...

R3 Vascular Inc. announced that the first patient was enrolled in the company’s ELITE-BTK pivotal trial evaluating its Magn ...

The SEC has postponed its decision on the Polkadot ETF, but investor sentiment remains strong. Discover the impact of this ...

This application can be made in parallel with Institutional Review Board/Domain Specific Review Board (IRB/DSRB) applications. Regulatory approval is issued independent of the IRB/DSRB approval.

ASX rebounds after Trump signals lower China tariffs; CBA retreats from record; James Hardie shorts mount; MinRes director exodus continues; Tesla rallies.